Related Experiment Video
Updated: Jul 2, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 10, 2011
Impact of methicillin resistance on mortality in Staphylococcus aureus endocarditis: a systematic review and
Durga Shankar Meena1, Deepak Kumar2, Gopal Krishana Bohra2
1Division of Infectious Diseases (Department of General Medicine), All India Institute of Medical Sciences, Jodhpur, India. dsmims14@gmail.com.
Background:
Methicillin-resistant Staphylococcus aureus (MRSA) has emerged as a leading cause of endocarditis with poor outcomes. The magnitude and consistency of its mortality risk compared with methicillin-susceptible S. aureus (MSSA) remain uncertain.
Methods:
Data were extracted from PubMed, Embase, Scopus, and Cochrane Library from database inception to 30 November 2025, without language restrictions. A random-effects model (Restricted Maximum-Likelihood) was used to calculate pooled risk ratios (RRs). Heterogeneity was explored by stratified and meta-regression analyses. Publication bias was assessed using funnel plot symmetry and Egger's regression.
Results:
Twenty-four studies, comprising 3291 patients (1,011 with MRSA and 2280 with MSSA), met the inclusion criteria. Pooled short-term mortality was significantly higher in MRSA endocarditis (30.9% vs 25.6%; RR 1.48, 95% CI 1.21-1.80; I² = 34%). Across stratified analyses by study design, setting, region, and study era, mortality remained consistently higher in MRSA endocarditis. No significant differences were found for heart failure (RR 1.08, 95% CI 0.90-1.30), embolic events (RR 0.82, 95% CI 0.51-1.33), stroke (RR 0.88, 95% CI 0.78-1.00), or surgery performed (RR 0.97, 95% CI 0.56-1.68) in MRSA and MSSA groups. No publication bias was revealed by Funnel-plot inspection and Egger's test (p = 0.082). Meta-regression showed no effect modification by age, hospital-acquired infection, prosthetic valve, or right-sided endocarditis.
Conclusions:
MRSA endocarditis carries a significantly higher short-term mortality than MSSA, consistent across study designs and study-level characteristics. The major complications were comparable between the two groups.
Insights
Methicillin-resistant Staphylococcus aureus (MRSA) endocarditis leads to higher short-term mortality compared to methicillin-susceptible S. aureus (MSSA). Major complications were similar between MRSA and MSSA endocarditis patients.
Area of Science:
- Infectious Diseases
- Cardiology
- Public Health
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of infective endocarditis.
- Outcomes for MRSA endocarditis are often poor, but comparative mortality risk versus MSSA is unclear.
Purpose of the Study:
- To quantify and assess the consistency of the mortality risk associated with MRSA endocarditis compared to MSSA endocarditis.
Main Methods:
- Systematic review and meta-analysis of studies from PubMed, Embase, Scopus, and Cochrane Library up to November 2025.
- Random-effects model used to calculate pooled risk ratios (RRs) for mortality.
- Heterogeneity and publication bias assessed via stratified analyses, meta-regression, funnel plots, and Egger's test.
Main Results:
- Twenty-four studies including 3291 patients (1011 MRSA, 2280 MSSA) were analyzed.
- MRSA endocarditis showed significantly higher short-term mortality (30.9% vs 25.6%; RR 1.48).
- Mortality remained higher in MRSA cases across various subgroup analyses; complications like heart failure, embolic events, stroke, and surgery rates were comparable.
Conclusions:
- MRSA endocarditis is associated with substantially higher short-term mortality than MSSA endocarditis.
- This increased mortality risk is consistent across different study designs and patient characteristics.
- Key complications of endocarditis do not significantly differ between MRSA and MSSA infections.
Related Concept Videos
Mitral Stenosis III: Medical Management
Endocarditis I: Introduction
Endocarditis III: Medical Management
Myocarditis III: Medical Management
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance

